Image

Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population

Recruiting
1 - 16 years of age
Both
Phase N/A

Powered by AI

Overview

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

Outcomes are:

  1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. scar appearance at a 6-months follow-up.

Description

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

After obtaining the patient's/parent's consent and randomization, the suture material will be provided.

Selection of the size of the thread and the date of the first follow-up are determined as

follows
  • Face: Thread size 5-0 to 7-0, first follow-up 4-7 days
  • Torso/back: Thread size 4-0 or 5-0, first follow-up 10-14 days
  • Arms: Thread size 4-0 or 5-0, first follow-up 7- 10 days
  • Hand: Thread size 5-0 or 6-0, first follow-up 7-10 days
  • Legs: Thread size 4-0 or 5-0, first follow-up 7-14 days

The patients are examined by in the outpatient wound clinic by specialised nurses under medical supervision at the first follow-up, and at six months by one of the investigators.

Outcomes
  1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. scar appearance at a 6-months follow-up.

Eligibility

Inclusion Criteria:

  • Patient younger than 16 years of age with a wound requiring suture

Exclusion Criteria:

  • Deep wounds with lesions of subcutaneous structures (tendons, nerves, etc.)
  • Wounds with tissue loss
  • Diabetic patients or patients treated with drugs potentially compromising cicatrization (e.g. steroids, immunosuppressors, etc.)
  • Wounds caused by animal or human bites
  • Sutures not performed in the emergency room
  • Heavily soiled wounds

Study details

Wounds and Injuries

NCT02777346

Pediatric Clinical Research Platform

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.